|
|
Article: Reports from S.J. Hua and co-researchers add new data to research in breast cancer.
- Article from:
- Gene Therapy Weekly
- Article date:
- August 27, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
"Retinoic acid (RA) triggers antiproliferative effects in tumor cells, and therefore RA and its synthetic analogs have great potential as anticarcinogenic agents. Retinoic acid receptors (RARs) mediate RA effects by directly regulating gene expression," scientists in the United States report (see also Breast Cancer).
"To define the genetic network regulated by RARs in breast cancer, we identified RAR genomic targets using chromatin immunoprecipitation and expression analysis. We found that RAR binding throughout the genome is highly coincident with estrogen receptor alpha (ER alpha) binding, resulting in a widespread crosstalk of RA and estrogen signaling to ...